BACKGROUND: The association between maternal age and risk of Down syndrome has been repeatedly shown in various populations. However, the effect of paternal age and education of parents has not been frequently studied. Comparative studies on Down syndrome are also rare. This study evaluates the epidemiological characteristics of Down syndrome in two culturally and socially contrasting population settings, in California and the Czech Republic. METHODS: The observed live birth prevalence of Down syndrome was studied among all newborns in the California counties monitored by California Birth Defects Monitoring Program from 1996 to 1997, and in the whole Czech Republic from 1994 to 1998. Logistic regression was used to analyze the data. RESULTS: A total of 516,745 (California) and 475,834 (the Czech Republic) infants were included in the analysis. Among them, 593 and 251, respectively, had Down syndrome. The mean maternal age of children with Down syndrome was 32.1 years in California and 26.9 years in the Czech Republic. Children born to older mothers were at greater risk of Down syndrome in both populations. The association with paternal age was mostly explained by adjusting for maternal age, but remained significant in the Czech Republic. The association between maternal education and Down syndrome was much stronger in California than in the Czech Republic but parental age influences higher occurrence of Down syndrome both in California and in the Czech Republic. CONCLUSION: The educational gradient in California might reflect selective impact of prenatal diagnosis, elective termination, and acceptance of prenatal diagnostic measures in Californian population.

Faculty of Science Charles University Czech Republic

Zobrazit více v PubMed

Pueschel SM, Anneren G, Durlach R, et al. Guidelines for optimal medical care of persons with Down syndrome. International League of Societies for Persons with Mental Handicap (ILSMH) Acta Paediatr. 1995;84:823–827. PubMed

Muchova J, Sustrova M, Garaiova I, et al. Influence of age on activities of antioxidant enzymes and lipid peroxidation products in erythrocytes and neutrophils of Down syndrome patients. Free Radic Biol Med. 2001;31:499–508. doi: 10.1016/S0891-5849(01)00609-8. PubMed DOI

Penrose LS. The relative effects of parental and maternal age in mongolism. J Genetics. 1933. pp. 27–219. PubMed

Lejeune J, Gautier M, Turpin R. Etude des chromosomes somatiques de neuf enfants mongoliens. CR Acad Sci Paris. 1959;248:1724–1722. PubMed

Steele MW, Breg WR. Chromosome analysis of human amniotic-fluid cells. Lancet. 1966;i:383–385. doi: 10.1016/S0140-6736(66)91387-0. PubMed DOI

Valenti C, Schutta EJ, Kehaty T. Prenatal diagnosis of Down's syndrome. Lancet. 1968;ii:220. doi: 10.1016/S0140-6736(68)92656-1. PubMed DOI

Hoshi N, Hattori R, Hanatani K, et al. Recent trends in the prevalence of Downs syndrome in Japan. American Journal of Medical Genetics. 1999;84:340–345. doi: 10.1002/(SICI)1096-8628(19990604)84:4<340::AID-AJMG6>3.0.CO;2-N. PubMed DOI

Carothers AD, Hecht CA, Hook EB. International variation in reported livebirth prevalence rates of Down syndrome, adjusted for maternal age. J Med Genet. 1999;36:386–393. PubMed PMC

Lopez PM, Stone D, Gilmour H. Epidemiology of Down's syndrome in a Scottish city. Paediatr Perinat Epidemiol. 1995;9:331–340. PubMed

Rosch C, Steinbicker V, Kropf S. Down's syndrome: the effects of prenatal diagnosis and demographic factors in a region of the eastern part of Germany. Eur J Epidemiol. 2000;16:627–632. doi: 10.1023/A:1007693025935. PubMed DOI

Torfs CP, Christianson RE. Effect of Maternal Smoking and Coffee Consumption on the Risk of Having a Recognized Down Syndrome Pregnancy. Am J Epidemiol. 2000;152:1185–1191. doi: 10.1093/aje/152.12.1185. PubMed DOI

Bishop J, Huether CA, Torfs C, Lorey F, Deddens J. Epidemiologic study of Down Syndrome in a racially diverse California population. Am J Epidemiol. 1997;145:134–147. PubMed

Hassold T, Sherman T. Down syndrome: genetic recombination and the origin of the extra chromosome 21. Clinical Genetics. 2000;57:95–100. doi: 10.1034/j.1399-0004.2000.570201.x. PubMed DOI

Alderson P. Down's syndrome: cost, quality and value of life. Soc Sci Med. 2001;53:627–638. doi: 10.1016/S0277-9536(00)00365-8. PubMed DOI

Learman LA, Kuppermann M, Gates E, Nease RF, Gildengorin V, Washington AE. Social and familial context of prenatal genetic testing decisions: Are there racial/ethnic differences? Am J Med Genet. 2003;119:19–26. doi: 10.1002/ajmg.c.10004. PubMed DOI

Kuppermann M, Gates E, Washington AE. Racial-ethnic differences in prenatal diagnostic test use and outcomes: preferences, socioeconomics, or patient knowledge? Obstet Gynecol. 1996;87:675–682. doi: 10.1016/0029-7844(96)00017-8. PubMed DOI

Kuppermann M, Nease RF, Learman LA, Gates E, Blumberg B, Washington AE. Procedure-related miscarriages and Down syndrome-affected births: implications for prenatal testing based on women's preferences. Obstet Gynecol. 2000;96:511–516. doi: 10.1016/S0029-7844(00)00969-8. PubMed DOI

Americans with Disabilities Act, Public Law 336 of the 101st Congress, July 26, 1990.

Roizen NJ, Patterson D. Down's syndrome. Lancet. 2003;361:1281–1289. doi: 10.1016/S0140-6736(03)12987-X. PubMed DOI

Smart RD. Down syndrome in the Cape Peninsula and the value of amniocentesis as a preventive measure. South African Medical Journal. 1981;59:670–672. PubMed

Kazaura MR, Lie RT. Down's syndrome and paternal age in Norway. Paediatr Perinat Epidemiol. 2002;164:314–319. doi: 10.1046/j.1365-3016.2002.00446.x. PubMed DOI

Congenital anomalies 1994-1998, Yearbook. (In Czech: Vrozene vady) UZIS, Prague.

de Michelena MI, Burstein E, Lama JR, Vasquez JC. Paternal age as a risk for Down syndrome. Am J Med Genet. 1993;45:679–682. doi: 10.1002/ajmg.1320450605. PubMed DOI

Harris RA, Washington AE, Nease RF, Jr, Kuppermann M. Cost utility of prenatal diagnosis and the risk-based threshold. The Lancet. 2004;363:276–282. doi: 10.1016/S0140-6736(03)15385-8. PubMed DOI

Cunningham GC, Tompkinson DG. Cost and effectiveness of the California triple marker prenatal screening program. Genet Med. 1999;1:199–206. PubMed

Wenstrom KD, Williamson RA, Grant SS, Hudson JD, Getchell JP. Evaluation of multiple-marker screening for Down syndrome in a statewide population. Am J Obstetr Gynecol. 1993;169:793–797. PubMed

Khosnood B, Blondel B, Breart G, Lee K-S, Pryde P, Schoendorf K. Comparison of the use of amniocentesis in two countries with different policies for prenatal testing: the case of France and the United States. Prenat Diagn. 2005;25:14–19. doi: 10.1002/pd.1075. PubMed DOI

State fact about Abortion, California. The Allan Guttmacher Institute. 2005.